17.92
-1.46(-7.53%)
Currency In USD
| Previous Close | 19.38 |
| Open | 19.16 |
| Day High | 19.65 |
| Day Low | 17.4 |
| 52-Week High | 46.2 |
| 52-Week Low | 3.6 |
| Volume | 210,511 |
| Average Volume | 192,200 |
| Market Cap | 124.65M |
| PE | -1.15 |
| EPS | -15.54 |
| Moving Average 50 Days | 9.65 |
| Moving Average 200 Days | 12.53 |
| Change | -1.46 |
If you invested $1000 in Scilex Holding Company (SCLX) since IPO date, it would be worth $51.98 as of August 19, 2025 at a share price of $17.92. Whereas If you bought $1000 worth of Scilex Holding Company (SCLX) shares 3 years ago, it would be worth $49.56 as of August 19, 2025 at a share price of $17.92.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Scilex Holding Company (Nasdaq: SCLX) Announces Effectiveness of Registration Statement on Form S-4 for the Proposed Business Combination of Denali Capital Acquisition Corp. and Semnur Pharmaceuticals, Inc., a Majority-Owned Subsidiary of Scilex
GlobeNewswire Inc.
Aug 13, 2025 10:00 AM GMT
Denali’s registration statement on Form S-4 declared effective by the Securities and Exchange CommissionExtraordinary general meeting of Denali Capital Acquisition Corp. shareholders to approve the proposed business combination is scheduled to be hel
Scilex Holding Company Announces Deferral of Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from May 2, 2025 to a future date to be determined by the Board
GlobeNewswire Inc.
Jun 23, 2025 8:50 PM GMT
PALO ALTO, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for
Scilex Holding Company Announces Publication on GLOPERBA® Dosing Adjustments in Peer-Review Journal
GlobeNewswire Inc.
Jun 05, 2025 4:05 PM GMT
PALO ALTO, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for